This research was supported by grants from the Capital Foundation of Medical Developments of China(CFMD2011402202);National Key Technology R&D Program(2015BAI13B06);research funding from Fujirebio Diagnostics,Inc.
Background::Human epididymis secretory protein 4(HE4)is a new ovarian cancer biomarker.The factors influencing HE4 levels are not clear,and the reference data in China are limited.Here,we aim to evaluate the effects o...